Evaluate the Pharmacokinetics, Safety, and Tolerability of Nirsevimab in Healthy Chinese Adults

Clinical trial NCT04840849 · COMPLETED

Trial details

NCT number: NCT04840849
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Evaluate PK Profile

Start date: 2021-06-22
Primary completion: 2021-11-18
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.